Market recap - week 26
These cannabis stocks crushed the markets this week!
| Company | Symbol | Change | Market cap Sort ascending | Volume | Price |
|---|---|---|---|---|---|
iAnthus Capital Holdings Inc.
|
IAN |
3,134.43%
|
$387,609,876 | $23,741 | $0,06 |
The Flowr Corporation
|
FLWR |
50.06%
|
$2,091,469 | $33,276 | $0,02 |
Integrated Cannabis Company Inc.
|
ICAN |
46.40%
|
$39,647,297 | $5,750 | $0,18 |
These cannabis stocks didn't do so well this week!
| Company | Symbol | Change | Market cap Sort ascending | Volume | Price |
|---|---|---|---|---|---|
CBD of Denver Inc.
|
CBDD |
-100.00%
|
$0 | $32,441 | $0,00 |
Applied Biosciences Corp.
|
APPB |
-42.86%
|
$3,910,518 | $366 | $0,20 |
MassRoots Inc.
|
MSRT |
-42.45%
|
$3,373,363 | $64,357 | $0,02 |
This week's most trending cannabis stocks in the news and social media.
CannTrust Holdings Inc. is establishing operations in the United States – with a $20m initial investment. This expansion will start in the State of California, where CannTrust has signed a non-binding letter of intent that will provide access to over 3,000 acres of farmland for hemp production with Elk Grove Farming Company to secure low-cost hemp with high cannabidiol (CBD) content.
MediPharm Labs Corp. announced it successfully completed its first export shipment of medical cannabis concentrate into Australia to AusCann Group Holdings Ltd. Through its wholly owned subsidiary, MediPharm Labs Inc., the Company has become the first Canadian extraction-only company to publicly announce that it has received an export permit from Health Canada for the shipment of cannabis solid concentrate, under the new regulations, from Canada to Australia. Prior to the shipment, the Australian Government’s Office of Drug Control Section also issued an import permit.
FSD Pharma Inc. announced that its wholly-owned subsidiary FV Pharma Inc. has received its Full Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The license is effective as of June 21, 2019.